Browsed by
Tag: 2021

2021 New Year’s Message by Victor Bjoerk

2021 New Year’s Message by Victor Bjoerk

logo_bg

Victor Bjoerk


2021 has arrived, and it’s time for my yearly New Year’s message!

Since we all know how the world has been affected this year, there’s no point in mentioning the virus, but quite a few things happened for me.

At the beginning of this year and spring I was living in San Francisco and working on aging at BioAge. However, BioAge had to temporarily shut down because of COVID, but this wasn’t a big deal for me since I was able to transfer to Ichor Therapeutics in Syracuse, New York, which remained operational. So I got to work at two awesome leading biotech companies in the Longevity field, where I gained a lot of specific know-how which I am very grateful for!

I returned to Europe a few weeks ago, and shortly I’ll have some more exciting things to announce that I will be working on!

So yes, a lot of lemons were handed out this year worldwide, but I felt I did a decent job at making lemonade out of them. I’m a very positive person with a grand vision of wiping out all age-related disease within the next few decades, so that everybody can live as long as they want in a 25-year old body.

Some do not have that approach, they think “Longevity” means some slight health improvement by diet/exercise. Others study some aspect of aging because they want a PhD and some academic credentials (using aging as an excuse to refer to for that); however, this causes a generalized lack of a big-picture perspective for what’s going to work.

That is not me. I robustly and consistently keep up the interest until the mission is fully accomplished. In my personal roadmap I’ve developed for impacting aging, I emphasize the transdisciplinary scientific fields that are going to produce good outcomes (that may be hidden as, e.g.,“proteomics” rather than explicitly stated as “anti-aging”).

I also put an equal weight on the “business aspect” here, since your impact won’t be that big without the correct biotech business know-how, especially as AI and robotics wipe out the lab workers. Drug development and clinical trials are complex fields with 15-20 years from initial discovery to approved product. In addition, raising capital and advocacy to the public are as important as knowing the basic biology itself.

A lot of things in history have also been grotesquely mismanaged and squandered because of predictable human error, not because of the intrinsic difficulty of the science itself. There are a lot of golden nuggets laying around the labs in the world right now, and lots of resources and techniques are at our fingertips, but how will they be combined and implemented into an individual in order to cure them from aging? And how will this cocktail of interventions that forms the ultimate cure of aging be implemented across the world just like the efforts currently underway with the COVID vaccine?

A lot of setbacks are reversible and temporary, such as a lack of money and success or whatever people feel this year has caused them; aging is profoundly more serious.

During the year I read, as usual, many hundreds of scientific papers to keep up with the aging field, and also I have several publications I’ve produced, coming out now during 2021 (unfortunately peer-review takes time). I participated in many aging conferences, including one in Curacao, which meant a week of swimming in the tropics (how enjoyable!).

So yes, I felt I did many things well despite the challenges. Of course, things could always have been done better in retrospect, but that’s what one always says.

My New Year’s celebration this year isn’t very special because of all restrictions, but I wish you all a happy new year!

I have some typical New Year’s resolutions like getting fitter (but not motivating with all gyms and pools being closed, so some coaching is required), and of course continuing with the aging mission. So I’ll leave the question now to the reader: What have you done this year, and what good do you feel you can do for next year?

Victor Bjoerk has worked for the Gerontology Research Group, the Longevity Reporter, the Fraunhofer-Institut für Zelltherapie und Immunologie, BioAge, and Ichor Therapeutics. He has promoted awareness throughout Europe of emerging biomedical research and the efforts to reverse biological aging. In his honor the U.S. Transhumanist Party organized the Victor Run 2020 Virtual Race on June 5-7, 2020.